Profit Or Loss [Abstract]

Xspray Pharma - Filing #679276

Concept	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue	—	—	– SEK	—	—	—	—	– SEK	—	—	—
Other income	—	—	31 767 SEK	—	—	—	—	2 180 SEK	—	—	—
Other expense, by function	—	—	3 675 SEK	—	—	—	—	3 433 SEK	—	—	—
Profit (loss) from operating activities	—	—	181 734 SEK	—	—	—	—	133 073 SEK	—	—	—
Finance income	—	—	2 725 SEK	—	—	—	—	1 415 SEK	—	—	—
Finance costs	—	—	675,000 SEK	—	—	—	—	12,000 SEK	—	—	—
Profit (loss) before tax	—	—	179 684 SEK	—	—	—	—	131 670 SEK	—	—	—
Tax expense (income)	—	—	17,000 SEK	—	—	—	—	– SEK	—	—	—
Profit (loss)	- SEK	- SEK	179 667 SEK	179 667 SEK	- SEK	– SEK	– SEK	131 670 SEK	131 670 SEK	- SEK	– SEK
Earnings per share [text block]	—	—	—	—	—	—	—	—	—	—	—
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share	—	—	676.00	—	—	—	—	625.00	—	—	—
Diluted earnings per share [abstract]
Diluted earnings (loss) per share	—	—	676.00	—	—	—	—	625.00	—	—	—